- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Nebraska Rejects Compromise Effort to Expand Medicaid
Nebraska legislators spent the past year crafting a conservative version of Obamacare's Medicaid expansion that they hoped would gain support in a pretty red state. But after a failed vote in the state legislature Wednesday, the Medicaid expansion is officially dead in Nebraska this year.
Nebraska legislators spent the past year crafting a conservative version of Obamacare’s Medicaid expansion that they hoped would gain support in a pretty red state. But after a failed vote in the state legislature Wednesday, the Medicaid expansion is officially dead in Nebraska this year.
So far, 25 states and Washington, DC.., have expanded their Medicaid programs in 2014, the first year of Obamacare coverage. With some exceptions, these are mostly blue states that joined the expansion, which was made optional by the Supreme Court’s 2012 decision on the health care law.
For this year and the following two years, the federal government is fully funding the expansion population for states that opt into the program. States can join at any time, but the 100 percent federal match starts going down after 2016, though it won’t drop below 90 percent.
Read the full story here: http://wapo.st/1gKeayh
Source: The Washington Post
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
